VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 119 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,855 | -61.8% | 198 | 0.0% | 0.00% | – |
| Q2 2023 | $4,857 | +22.8% | 198 | +16.5% | 0.00% | – |
| Q1 2023 | $3,956 | -100.0% | 170 | -100.0% | 0.00% | -100.0% |
| Q4 2022 | $27,825,662 | +695541.6% | 1,099,394 | +538818.6% | 0.14% | – |
| Q3 2022 | $4,000 | -100.0% | 204 | -100.0% | 0.00% | -100.0% |
| Q2 2022 | $19,979,000 | +285314.3% | 784,411 | +288286.4% | 0.15% | – |
| Q1 2022 | $7,000 | -50.0% | 272 | -19.8% | 0.00% | – |
| Q4 2021 | $14,000 | +75.0% | 339 | +86.3% | 0.00% | – |
| Q3 2021 | $8,000 | -11.1% | 182 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | -89.9% | 182 | -89.5% | 0.00% | -100.0% |
| Q1 2021 | $89,000 | -23.9% | 1,739 | -60.3% | 0.00% | 0.0% |
| Q4 2020 | $117,000 | +1850.0% | 4,378 | +2445.3% | 0.00% | – |
| Q3 2020 | $6,000 | +50.0% | 172 | +100.0% | 0.00% | – |
| Q2 2020 | $4,000 | – | 86 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |